Skip to content
Wednesday, August 26, 2026
Women's Health Trial Tracker — 2017
| Record | Record Date | Vuga Group | Change Status | Recency Days | Public Significance Score |
|---|
| A Phase II, Two-Arm Study of Everolimus and Letrozole, +/- Ribociclib (Lee011) in Patients With Advanced or Recurrent Endometrial Carcinoma | 01/02/2017 | INTERVENTIONAL | unchanged | 3,523.85 | 0 |
|---|
| Prognostic and Predictive Biomarkers in Ovarian Cancers | 01/04/2017 | INTERVENTIONAL | unchanged | 3,521.85 | 0 |
|---|
| Fertility Preservation Using Tamoxifen and Letrozole in Estrogen Sensitive Tumors Trial | 01/05/2017 | INTERVENTIONAL | unchanged | 3,520.85 | 0 |
|---|
| Multi-epitope Folate Receptor Alpha Peptide Vaccine, GM-CSF, and Cyclophosphamide in Treating Patients With Triple Negative Breast Cancer | 01/06/2017 | INTERVENTIONAL | unchanged | 3,519.85 | 0 |
|---|
| Hypnosedation in Relaxing Patients Undergoing Breast Cancer Surgery | 01/06/2017 | INTERVENTIONAL | unchanged | 3,519.85 | 0 |
|---|
| Study of Niraparib and TSR-042 in Recurrent Endometrial Cancer | 01/10/2017 | INTERVENTIONAL | unchanged | 3,515.85 | 0 |
|---|
| Genetically Modified T Cells and Decitabine in Treating Patients With Recurrent or Refractory Ovarian, Primary Peritoneal, or Fallopian Tube Cancer | 01/11/2017 | INTERVENTIONAL | unchanged | 3,514.85 | 0 |
|---|
| Heart Attack Research Program: Platelet Sub-Study (HARP) | 01/16/2017 | OBSERVATIONAL | unchanged | 3,509.85 | 0 |
|---|
| Two Therapeutic Strategies in First-line in Patients With Epithelial Advanced Ovarian Cancer | 01/19/2017 | INTERVENTIONAL | unchanged | 3,506.85 | 0 |
|---|
| Texting for Diabetes | 01/20/2017 | INTERVENTIONAL | unchanged | 3,505.85 | 0 |
|---|
| Phase 2 Study of Pembrolizumab, DPX-Survivac Vaccine and Cyclophosphamide in Advanced Ovarian, Primary Peritoneal or Fallopian Tube Cancer | 01/24/2017 | INTERVENTIONAL | unchanged | 3,501.85 | 0 |
|---|
| Hysterectomy and OPPortunistic SAlpingectomy | 02/08/2017 | INTERVENTIONAL | unchanged | 3,486.85 | 0 |
|---|
| Electrophysiology of Fetal Arrhythmia | 02/08/2017 | OBSERVATIONAL | unchanged | 3,486.85 | 0 |
|---|
| Video-Feedback Interaction Guidance for Improving Interactions Between Depressed Mothers and Their Infants ("VID-KIDS") | 02/14/2017 | INTERVENTIONAL | unchanged | 3,480.85 | 0 |
|---|
| Materiovigilance After Urinary Incontinence or Prolapse Surgery | 02/14/2017 | OBSERVATIONAL | unchanged | 3,480.85 | 0 |
|---|
| Comparison of the Efficacy of Sacrocolpopexy, the Amreich-Richter Procedure and Transvaginal Mesh | 02/15/2017 | INTERVENTIONAL | unchanged | 3,479.85 | 0 |
|---|
| Interest of Myo-inositol Supplementation in Women With Polycystic Ovarian Syndrome | 02/23/2017 | INTERVENTIONAL | unchanged | 3,471.85 | 0 |
|---|
| Screening for Anal Cancer in Women With High-grade Vulvar Dysplasia or Vulvar Cancer. | 02/23/2017 | INTERVENTIONAL | unchanged | 3,471.85 | 0 |
|---|
| Validation of Human Papillomavirus Assays and Collection Devices for Self-samples and Urine Samples | 02/24/2017 | OBSERVATIONAL | unchanged | 3,470.85 | 0 |
|---|
| Hyperandrogenemia and Altered Day-night LH Pulse Patterns | 03/03/2017 | INTERVENTIONAL | unchanged | 3,463.85 | 0 |
|---|
| PORTAL: Patient-reported Outcomes After Routine Treatment of Atypical Lesions | 03/03/2017 | INTERVENTIONAL | unchanged | 3,463.85 | 0 |
|---|
| Vitamin B12 Supplementation During Pregnancy on Cognitive Development | 03/07/2017 | INTERVENTIONAL | unchanged | 3,459.85 | 0 |
|---|
| Toxicity and Outcome of Whole Breast Hypofractionated Radiotherapy: a Single Institution Experience | 03/10/2017 | OBSERVATIONAL | unchanged | 3,456.85 | 0 |
|---|
| Migraine and CVD Risk in Women | 03/16/2017 | INTERVENTIONAL | unchanged | 3,450.85 | 0 |
|---|
| Strategies for Pregnancy Achievement | 03/21/2017 | INTERVENTIONAL | unchanged | 3,445.85 | 0 |
|---|
| POWERMOM, A Healthy Pregnancy Research Community | 03/21/2017 | OBSERVATIONAL | unchanged | 3,445.85 | 0 |
|---|
| Fetoscopic Repair of Isolated Fetal Spina Bifida | 03/27/2017 | INTERVENTIONAL | unchanged | 3,439.85 | 0 |
|---|
| Neoadjuvant Weekly Paclitaxel and Biomarkers of Therapy Response | 03/30/2017 | INTERVENTIONAL | unchanged | 3,436.85 | 0 |
|---|
| Study of Food Aversion in Patients With Anorexia Nervosa | 04/04/2017 | INTERVENTIONAL | unchanged | 3,431.85 | 0 |
|---|
| Assessment of Gemcitabine as Chemoradiotherapy in Patients With Locally Advanced Carcinoma of Cervix and Renal Disease | 04/05/2017 | INTERVENTIONAL | unchanged | 3,430.85 | 0 |
|---|
| Autologous Muscle Derived Cells Compared to Placebo for Urinary Sphincter Repair in Post-surgical Female Stress Incontinence | 04/07/2017 | INTERVENTIONAL | unchanged | 3,428.85 | 0 |
|---|
| Predictors of Postoperative Pain Following Oocyte Retrieval for Assisted Reproduction | 04/10/2017 | INTERVENTIONAL | unchanged | 3,425.85 | 0 |
|---|
| Can Conventional ECG Technology Capture Fetal Cardiac Activity? | 04/12/2017 | INTERVENTIONAL | unchanged | 3,423.85 | 0 |
|---|
| The 3D Cohort Study (Design, Develop, Discover) | 04/13/2017 | OBSERVATIONAL | unchanged | 3,422.85 | 0 |
|---|
| P53MVA and Pembrolizumab in Treating Patients With Recurrent Ovarian, Primary Peritoneal, or Fallopian Tube Cancer | 04/13/2017 | INTERVENTIONAL | unchanged | 3,422.85 | 0 |
|---|
| Blocking Blue Light in Pregnancy, Effects on Melatonin Profile and Sleep | 04/14/2017 | INTERVENTIONAL | unchanged | 3,421.85 | 0 |
|---|
| VSV-hIFNbeta-NIS With or Without Ruxolitinib Phosphate in Treating Stage IV or Recurrent Endometrial Cancer | 04/19/2017 | INTERVENTIONAL | unchanged | 3,416.85 | 0 |
|---|
| Outcome of 15 Versus 5 Fractions in Adjuvant Breast Radiotherapy in Women Over 65 Years | 04/20/2017 | INTERVENTIONAL | unchanged | 3,415.85 | 0 |
|---|
| Vagal Stimulation in POTS | 04/21/2017 | INTERVENTIONAL | unchanged | 3,414.85 | 0 |
|---|
| Clinical Trial of Atezolizumab With Paclitaxel, Trastuzumab, and Pertuzumab in Patients With Metastatic HER-2 Positive Breast Cancer | 04/24/2017 | INTERVENTIONAL | unchanged | 3,411.85 | 0 |
|---|
| Hypofractionated vs Standard Radiotherapy in Breast Cancer With an Indication for Regional Lymph Node Irradiation About Lymphedema Occurrence | 04/25/2017 | INTERVENTIONAL | unchanged | 3,410.85 | 0 |
|---|
| Effects of Chemotherapy on Cognitive Function in Breast Cancer Patients & Non-Cancer Control Subjects With Optional Sub-Study Research Brain MRI | 05/02/2017 | OBSERVATIONAL | unchanged | 3,403.85 | 0 |
|---|
| Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia (FETO) | 05/03/2017 | INTERVENTIONAL | unchanged | 3,402.85 | 0 |
|---|
| Decision Aid Website in Helping to Make Decisions About Fertility in Participants With Cancer | 05/05/2017 | INTERVENTIONAL | unchanged | 3,400.85 | 0 |
|---|
| PRECAMA: Molecular Subtypes of Premenopausal Breast Cancer in Latin American Women | 05/09/2017 | OBSERVATIONAL | unchanged | 3,396.85 | 0 |
|---|
| Early Detection of Breast Cancer in Women With Suspicious Mammograms | 05/10/2017 | OBSERVATIONAL | unchanged | 3,395.85 | 0 |
|---|
| Multicenter Interventional Lymphangioleiomyomatosis (LAM) Early Disease Trial | 05/12/2017 | INTERVENTIONAL | unchanged | 3,393.85 | 0 |
|---|
| IMPACT Study: IMProve Pregnancy in APS With Certolizumab Therapy | 05/12/2017 | INTERVENTIONAL | unchanged | 3,393.85 | 0 |
|---|
| Evaluating the Safety and Efficacy of Long-Acting Injectable Cabotegravir Compared to Daily Oral TDF/FTC for Pre-Exposure Prophylaxis in HIV-Uninfected Women | 05/23/2017 | INTERVENTIONAL | unchanged | 3,382.85 | 0 |
|---|
| Comparison of the Breast Tumor Microenvironment | 05/24/2017 | OBSERVATIONAL | unchanged | 3,381.85 | 0 |
|---|
| CODEPAD (Collaborative Outcomes of DEpression and Pain Associated With Delivery) | 05/30/2017 | INTERVENTIONAL | unchanged | 3,375.85 | 0 |
|---|
| A Randomized Controlled Trial of Neoadjuvant Weekly Paclitaxel Versus Weekly Paclitaxel Plus Weekly Carboplatin In Women With Large Operable or Locally Advanced, Triple Negative Breast Cancer | 05/30/2017 | INTERVENTIONAL | unchanged | 3,375.85 | 0 |
|---|
| Comparing One or Two Doses of the Human Papillomavirus Vaccine for the Prevention of Human Papillomavirus Infection, ESCUDDO Study | 06/08/2017 | INTERVENTIONAL | unchanged | 3,366.85 | 0 |
|---|
| Female Fertility Preservation Using Ovarian Tissue Cryopreservation Before Highly Gonadotoxic Cancer Treatment | 06/08/2017 | INTERVENTIONAL | unchanged | 3,366.85 | 0 |
|---|
| UTHealth Turner Syndrome Research Registry | 06/14/2017 | OBSERVATIONAL | unchanged | 3,360.85 | 0 |
|---|
| A National Registry on Chinese Patients With Lymphangioleiomyomatosis | 06/21/2017 | OBSERVATIONAL | unchanged | 3,353.85 | 0 |
|---|
| Addition of Cisplatin to Adjuvant Chemotherapy for Early Stage Breast Cancer in High-Risk Women | 06/28/2017 | INTERVENTIONAL | unchanged | 3,346.85 | 0 |
|---|
| The Ma'Anshan Birth Cohort (MABC) | 07/12/2017 | OBSERVATIONAL | unchanged | 3,332.85 | 0 |
|---|
| Intraoperative Radiation Therapy (IORT) in DCIS | 07/13/2017 | INTERVENTIONAL | unchanged | 3,331.85 | 0 |
|---|
| Perioperative Music Listening on Anxiety, Analgesia Use and Patient Satisfaction | 07/21/2017 | INTERVENTIONAL | unchanged | 3,323.85 | 0 |
|---|
| An Examination of Infants' Microbiome, Nutrition, and Development Study. | 07/26/2017 | INTERVENTIONAL | unchanged | 3,318.85 | 0 |
|---|
| Oxytocin and Fetal Heart Rate Changes | 07/28/2017 | INTERVENTIONAL | unchanged | 3,316.85 | 0 |
|---|
| Digital Tomosynthesis Mammography and Digital Mammography in Screening Patients for Breast Cancer | 07/28/2017 | INTERVENTIONAL | unchanged | 3,316.85 | 0 |
|---|
| Nature Sounds as a Pain and Anxiety Reducing Strategy in Patients Undergoing Breast Core Biopsy | 08/03/2017 | INTERVENTIONAL | unchanged | 3,310.85 | 0 |
|---|
| Postoperative Hypofractionated Intensity-modulated Radiation Therapy in Cervical Cancer | 08/04/2017 | INTERVENTIONAL | unchanged | 3,309.85 | 0 |
|---|
| Radiation Therapy or Chemoradiation, Interstitial Brachytherapy in Combination With Hyperthermia in Advanced Cervical Cancer | 08/15/2017 | INTERVENTIONAL | unchanged | 3,298.85 | 0 |
|---|
| Predictive Role of New Biomarkers for Hypersensitive Patients to Radiation in Breast Cancer (BIORISE) | 08/17/2017 | INTERVENTIONAL | unchanged | 3,296.85 | 0 |
|---|
| Uterus Transplantation From a Multi-organ Donor | 08/17/2017 | INTERVENTIONAL | unchanged | 3,296.85 | 0 |
|---|
| Sentinel Lymph Node Biopsy After Neoadjuvant Chemotherapy For Locally Advanced Breast Cancer | 08/21/2017 | INTERVENTIONAL | unchanged | 3,292.85 | 0 |
|---|
| PrEP-Pod-IVR (TDF-FTC/Placebo IVR 28 Day Crossover Study) | 08/21/2017 | INTERVENTIONAL | unchanged | 3,292.85 | 0 |
|---|
| The INFLUENCE of Cytoreduction on PRO in EOC | 08/31/2017 | OBSERVATIONAL | unchanged | 3,282.85 | 0 |
|---|
| Randomized Study of Elective Regional Lymph Node Irradiation in N1 Breast Cancer | 09/01/2017 | INTERVENTIONAL | unchanged | 3,281.85 | 0 |
|---|
| Her2-BATS and Pembrolizumab in Metastatic Breast Cancer | 09/05/2017 | INTERVENTIONAL | unchanged | 3,277.85 | 0 |
|---|
| HIPEC in Ovarian Carcinoma Clinical Stage IIIC and IV During Interval Laparotomy | 09/07/2017 | INTERVENTIONAL | unchanged | 3,275.85 | 0 |
|---|
| Maternal Autoimmune Disease Research Alliance (MADRA) Registry | 09/08/2017 | OBSERVATIONAL | unchanged | 3,274.85 | 0 |
|---|
| Optimizing Brachytherapy Application and Delivery With MRI Guidance for Gynecologic Cancer | 09/11/2017 | INTERVENTIONAL | unchanged | 3,271.85 | 0 |
|---|
| Fetal Cystoscopy for Severe Lower Urinary Tract Obstruction | 09/13/2017 | INTERVENTIONAL | unchanged | 3,269.85 | 0 |
|---|
| Genetic Analysis in Blood and Tumor Samples From Patients With Advanced or Metastatic Estrogen Receptor Positive and HER2 Negative Breast Cancer Receiving Palbociclib and Endocrine Therapy | 09/13/2017 | OBSERVATIONAL | unchanged | 3,269.85 | 0 |
|---|
| Tailoring NEOadjuvant Therapy in Hormone Receptor Positive, HER2 Negative, Luminal Breast Cancer. | 09/14/2017 | INTERVENTIONAL | unchanged | 3,268.85 | 0 |
|---|
| The French E3N Prospective Cohort Study | 09/15/2017 | OBSERVATIONAL | unchanged | 3,267.85 | 0 |
|---|
| CDK 4/6 Inhibitor, Ribociclib, With Adjuvant Endocrine Therapy for ER-positive Breast Cancer | 09/18/2017 | INTERVENTIONAL | unchanged | 3,264.85 | 0 |
|---|
| Tailoring Mobile Health Technology to Reduce Obesity and Improve Cardiovascular Health in Resource-Limited Neighborhood Environments | 09/20/2017 | INTERVENTIONAL | unchanged | 3,262.85 | 0 |
|---|
| Evaluate The Accuracy Of Breast MRI Biopsy In Diagnosing A Complete Tumor Response For Some Women Following Neoadjuvant Chemotherapy For Breast Cancer | 09/20/2017 | INTERVENTIONAL | unchanged | 3,262.85 | 0 |
|---|
| Subclinical Lymphedema Treatment Study | 09/25/2017 | INTERVENTIONAL | unchanged | 3,257.85 | 0 |
|---|
| Brace Monitoring for Adolescent Idiopathic Scoliosis (AIS) | 09/25/2017 | INTERVENTIONAL | unchanged | 3,257.85 | 0 |
|---|
| Prospective Cohort Study of Germline Variant Carriers With BRCA1 or BRCA2 | 09/28/2017 | OBSERVATIONAL | unchanged | 3,254.85 | 0 |
|---|
| The Effects of the Female Hormones on Cerebral Perfusion | 10/02/2017 | OBSERVATIONAL | unchanged | 3,250.85 | 0 |
|---|
| Group Versus Traditional Prenatal Care for Diabetes | 10/04/2017 | INTERVENTIONAL | unchanged | 3,248.85 | 0 |
|---|
| The Value of Advanced Imaging Sequences for Fetal MRI in Clinical Practice | 10/05/2017 | INTERVENTIONAL | unchanged | 3,247.85 | 0 |
|---|
| Combined Breast MRI and Biomarker Strategies in Identifying High-risk Breast Cancer Patients | 10/06/2017 | INTERVENTIONAL | unchanged | 3,246.85 | 0 |
|---|
| The University of Pennsylvania Uterus Transplant for Uterine Factor Infertility Trial | 10/11/2017 | INTERVENTIONAL | unchanged | 3,241.85 | 0 |
|---|
| Extended Follow-up of Women Who Received One, Two, and Three Doses of the HPV Vaccine in the Costa Rica Vaccine Trial (CVT), ESCUDDO-CVT Study | 10/13/2017 | OBSERVATIONAL | unchanged | 3,239.85 | 0 |
|---|
| Berlin-Brandenburg Pregnancy Cohort | 10/18/2017 | OBSERVATIONAL | unchanged | 3,234.85 | 0 |
|---|
| Phase I Trial of Endoxifen Gel Versus Placebo in Women Undergoing Breast Surgery | 10/23/2017 | INTERVENTIONAL | unchanged | 3,229.85 | 0 |
|---|
| Positron Emission Tomography (PET) Imaging With Zirconium-89 (89Zr)-Trastuzumab for Prediction of HER2 Targeted Therapy Effectiveness | 10/25/2017 | INTERVENTIONAL | unchanged | 3,227.85 | 0 |
|---|
| Simvastatin Plus Dual Anti-HER2 Therapy for Metastatic Breast Cancer | 10/27/2017 | INTERVENTIONAL | unchanged | 3,225.85 | 0 |
|---|
| Efficacy of Denosumab on Normal BMD in Women Receiving Adjuvant Aromatase Inhibitors for Early Breast Cancer | 10/30/2017 | INTERVENTIONAL | unchanged | 3,222.85 | 0 |
|---|
| Trial of Posture Correction Girdle for Adolescents With Early Scoliosis | 11/06/2017 | INTERVENTIONAL | unchanged | 3,215.85 | 0 |
|---|
| A Study of GDC-9545 Alone or in Combination With Palbociclib and/or Luteinizing Hormone-Releasing Hormone (LHRH) Agonist in Locally Advanced or Metastatic Estrogen Receptor-Positive Breast Cancer | 11/06/2017 | INTERVENTIONAL | unchanged | 3,215.85 | 0 |
|---|
| Assessment of Breast Cancer Patients Satisfaction and Health Related Quality of Life Outcomes | 11/06/2017 | OBSERVATIONAL | unchanged | 3,215.85 | 0 |
|---|
| High Intensity Focused Ultrasound Treatment of Breast Tumors. BRIFU Study | 11/17/2017 | INTERVENTIONAL | unchanged | 3,204.85 | 0 |
|---|
| Antiviral Prophylaxis and Infant Vaccination to Prevent Perinatal Hepatitis B Infection | 11/17/2017 | INTERVENTIONAL | unchanged | 3,204.85 | 0 |
|---|
| Tazemetostat in Treating Patients With Recurrent Ovarian or Endometrial Cancer | 11/21/2017 | INTERVENTIONAL | unchanged | 3,200.85 | 0 |
|---|
| Bupivacaine vs Placebo for Unilateral Mastectomy Surgical Site Post-operative Pain Control | 11/22/2017 | INTERVENTIONAL | unchanged | 3,199.85 | 0 |
|---|
| An Analysis of Adverse Events and Satisfaction Outcomes of Women Who Underwent Primary and Secondary Breast Augmentation Using Silimed® Breast Implants | 11/29/2017 | OBSERVATIONAL | unchanged | 3,192.85 | 0 |
|---|
| Community-Based Lifestyle Intervention for Diabetes Prevention in Arab Women | 12/02/2017 | INTERVENTIONAL | unchanged | 3,189.85 | 0 |
|---|
| Nurse-Family Partnership Impact Evaluation in South Carolina | 12/04/2017 | INTERVENTIONAL | unchanged | 3,187.85 | 0 |
|---|
| PVX-410 Vaccine Plus Pembrolizumab in HLA-A2+ Metastatic Triple Negative Breast Cancer | 12/05/2017 | INTERVENTIONAL | unchanged | 3,186.85 | 0 |
|---|
| Breast Cancer Study of Preoperative Pembrolizumab + Radiation | 12/08/2017 | INTERVENTIONAL | unchanged | 3,183.85 | 0 |
|---|
| Niraparib in Combination With Trastuzumab in Metastatic HER2+ Breast Cancer | 12/11/2017 | INTERVENTIONAL | unchanged | 3,180.85 | 0 |
|---|
| In Utero Alcoholic Exposure: PlGF, Biomarker of Fetal Brain Lesions | 12/13/2017 | INTERVENTIONAL | unchanged | 3,178.85 | 0 |
|---|
| Breast Cancer Screening: Digital Breast Tomosynthesis Versus Digital 2D Mammography | 12/19/2017 | INTERVENTIONAL | unchanged | 3,172.85 | 0 |
|---|
| Capecitabine 7/7 Schedule With Neratinib in Patients With Metastatic HER2-Positive Breast Cancer | 12/19/2017 | INTERVENTIONAL | unchanged | 3,172.85 | 0 |
|---|
| Trial of Ibrutinib Plus Trastuzumab in HER2-amplified Metastatic Breast Cancer | 12/20/2017 | INTERVENTIONAL | unchanged | 3,171.85 | 0 |
|---|
| Preservation of Ovarian Cortex Tissue in Girls With Turner Syndrome | 12/21/2017 | INTERVENTIONAL | unchanged | 3,170.85 | 0 |
|---|
| Dexmedetomidine Wound Infiltration in Cesarean Section | 12/26/2017 | INTERVENTIONAL | unchanged | 3,165.85 | 0 |
|---|
| International Validation Study of Sentinel Node Biopsy in Early Cervical Cancer | 12/29/2017 | INTERVENTIONAL | unchanged | 3,162.85 | 0 |
|---|